Prospect of Stem Cell Conditioned Medium in Regenerative Medicine
Top Cited Papers
Open Access
- 28 August 2014
- journal article
- review article
- Published by Hindawi Limited in BioMed Research International
- Vol. 2014, 1-14
- https://doi.org/10.1155/2014/965849
Abstract
Background.Stem cell-derived conditioned medium has a promising prospect to be produced as pharmaceuticals for regenerative medicine.Objective.To investigate various methods to obtain stem cell-derived conditioned medium (CM) to get an insight into their prospect of application in various diseases.Methods.Systematic review using keywords “stem cell” and “conditioned medium” or “secretome” and “therapy.” Data concerning treated conditions/diseases, type of cell that was cultured, medium and supplements to culture the cells, culture condition, CM processing, growth factors and other secretions that were analyzed, method of application, and outcome were noted, grouped, tabulated, and analyzed.Results.Most of CM using studies showed good results. However, the various CM, even when they were derived from the same kind of cells, were produced by different condition, that is, from different passage, culture medium, and culture condition. The growth factor yields of the various types of cells were available in some studies, and the cell number that was needed to produce CM for one application could be computed.Conclusion.Various stem cell-derived conditioned media were tested on various diseases and mostly showed good results. However, standardized methods of production and validations of their use need to be conducted.Keywords
Funding Information
- Indonesian Ministry of Education and Culture (2218/H2.R12/HKP.05.00/2014)
This publication has 49 references indexed in Scilit:
- Conditioned Medium from Bone Marrow-Derived Mesenchymal Stem Cells Improves Recovery after Spinal Cord Injury in Rats: An Original Strategy to Avoid Cell TransplantationPLOS ONE, 2013
- The Relative Contribution of Paracine Effect versus Direct Differentiation on Adipose-Derived Stem Cell Transplantation Mediated Cardiac RepairPLOS ONE, 2013
- Human Embryonic Mesenchymal Stem Cell-Derived Conditioned Medium Rescues Kidney Function in Rats with Established Chronic Kidney DiseasePLOS ONE, 2012
- Reversal of endothelial progenitor cell dysfunction in patients with type 2 diabetes using a conditioned medium of human embryonic stem cell‐derived endothelial cellsDiabetes/Metabolism Research and Reviews, 2012
- Modeling the NF-κB mediated inflammatory response predicts cytokine waves in tissueBMC Systems Biology, 2011
- Therapeutic effects of human STRO‐3‐selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemiaJournal of Cellular and Molecular Medicine, 2010
- CD133 Identifies a Human Bone Marrow Stem/Progenitor Cell Sub-population With a Repertoire of Secreted Factors That Protect Against StrokeMolecular Therapy, 2009
- Novel Cell-Free Strategy for Therapeutic Angiogenesis: In Vitro Generated Conditioned Medium Can Replace Progenitor Cell TransplantationPLOS ONE, 2009
- Role of platelet-derived growth factors in physiology and medicineGenes & Development, 2008
- Mesenchymal Stem Cell-Derived Molecules Reverse Fulminant Hepatic FailurePLOS ONE, 2007